This study looked at spectral analysis of heart rate variability (HRV) between patients with type 2 diabetes mellitus (DM) and healthy controls. The association between diabetic autonomic neuropathy (DAN) with HRV parameter changes and DM risk factors (including nephropathy) was investigated. HRV parameters were compared between 271 patients with DM and 160 controls. A statistically significant difference was found between the two groups for each parameter. Patients with DM were then divided into three groups by the levels of individual risk factors: body mass index, total cholesterol, 2-h postprandial plasma glucose concentration, glycosylated haemoglobin, duration of DM and the albumin-creatinine ratio. HRV parameters decreased significantly in patients with DM as the risk factor level progressed.
Introduction
Autonomic neuropathy is a frequent complication of diabetes mellitus (DM). 1 − 4 Damage to the sympathetic and parasympathetic pathways to the heart is particularly dangerous for the patient. 5, 6 Although diabetic autonomic neuropathy (DAN) is traditionally considered as one of the late complications of DM, it is in fact a severe and relatively early complication. 7 -14 Early diagnosis of cardiac irregularity in patients with DM is very important, because those who develop DAN have a markedly higher mortality rate compared with those who have a normal cardiac function. 15 -17 In patients with DAN, a decrease in J-Y Hsiao, K-J Tien, C-T Hsiao et al. Diabetic autonomic neuropathy and diabetic risk factors parasympathetic tone occurs at night, and the nocturnal predominance of sympathetic activity may predispose these patients to cardiovascular events. 18, 19 Thus, identification of early and/or asymptomatic autonomic neuropathy may be important for cardiovascular risk stratification in the diabetic population.
A study in 1982 suggested that microalbuminuria represents an early stage in the progression to overt nephropathy. 20 Subsequent research in adults 21 and adolescents 22 has shown that fewer patients with microalbuminuria progress to nephropathy than was initially suggested. No study has directly related micro albuminuria to abnormalities of the autonomic nerves, and whether autonomic neuropathy has a causative role in the development of nephropathy remains unknown.
Heart rate variability (HRV) is a noninvasive electrocardiographic marker, reflecting the activity of the sympathetic and vagal components of the autonomic nervous system (ANS) on the sinus node of the heart. Thus, HRV analyses the tonic baseline autonomic function. In patients with DAN, changes in activity in the afferent and efferent fibres of the ANS and in local neural regulation contribute to sympathovagal imbalance, which is reflected by a reduced HRV.
Spectral analysis of short-term R-R variability, estimated by autoregressive modelling, is a recently developed method for evaluating cardiovascular autonomic function that also allows the study of the interaction of the parasympathetic and sympathetic systems. In DAN, parasympathetic impairment occurs earlier and is more relevant than sympathetic impairment. 23 In normal subjects, spectral analysis of R-R variability shows two major peaks: one at low frequency (LF), which is mainly an expression of sympathetic control, 24 and one at high frequency (HF), which represents vagal control. The LF component of the spectrum is more frequently abnormal than the HF component in patients with DAN, suggesting that early damage occurs in the sympathetic pathways to the heart in diabetic patients.
The aim of the present study was to compare autonomic nervous function in patients with type 2 DM with different stages of nephropathy, in order to identify possible links between autonomic neuropathy and nephropathy.
Patients and methods

PARTICIPANTS
Taiwanese patients with type 2 DM who were attending the Endocrine Clinic in the Division of Endocrinology and Metabolism at Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, between January 2008 and April 2009, were enrolled in this study. Normal healthy volunteers who were institute staff, medical students and their relatives, were included as control subjects. To be included in this study, patients had to have been diagnosed with type 2 DM and been followed up regularly, every 3 -6 months in the outpatient departments of Kaohsiung Medical University Hospital. Participants with a history of cardiovascular system disease, any concurrent illness and those taking medications known to influence cardiac, vascular or autonomic function were excluded.
The study was approved by the Ethical Committee of Kaohsiung Medical University Hospital, and all patients and control subjects provided written informed consent.
LABORATORY TESTS
Experienced research staff recorded each participant's age, gender, DM duration,
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height and weight on entry to the study. Body mass index (BMI; weight in kg divided by height in m 2 ) was calculated for each participant. Systolic and diastolic blood pressures were recorded by standard mercury sphygmomanometer. Fasting blood samples (no caloric intake for ≥ 8 h) were taken to measure serum total cholesterol (TC), highdensity lipoprotein cholesterol, low-density lipoprotein cholesterol, alanine aminotransferase, aspartate aminotransferase, plasma glucose, triglyceride (TG), C-reactive protein and glycosylated haemoglobin (HbA 1c ). Albumin-creatinine ratio (ACR) (µg albumin/mg creatinine) and 2-h postprandial plasma glucose (PPG) concentrations were also measured in random, spot collections. TC and TG were measured by a biochemical analyser (Synchron CX5CE; Beckman Coulter Inc., Brea, CA, USA). The TC and TG levels were analysed using the cholesterol oxidaseperoxidase method and the lipase-glucose oxidase-peroxidase method, respectively, using commercially available kits (Beckman Coulter Inc.). All other analyses were undertaken using standard laboratory techniques.
DATA ANALYSIS AND DIAGNOSTIC TESTS FOR DAN
For each participant, electrocardiograph (ECG) readings were collected for 10 − 15 min while they were lying in a prone position. HRV was analysed by an autonomic neurological analyser (Wegene Technologies Inc., Hualien, Taiwan). Beat-to-beat rate variation was measured with the patient at rest and supine, having had no overnight coffee or hypoglycaemic episodes, breathing 16 breaths/min and with heart rate monitored by ECG. A difference in heart rate of > 15 beats/min was considered normal and < 10 beats/min was considered abnormal. An R-R inspiration/R-R expiration ratio > 1.17 was considered to be normal. All indices of HRV are age-dependent.
STATISTICAL ANALYSES
The numerical variables were expressed as mean ± SD. Statistical analyses were performed with STATA ® software, version 10.1 (StataCorp LP, College Station, TX, USA). A Student's t-test was used to analyse continuous data and the χ 2 -test was used for the analysis of PPG concentrations, HbA 1c levels, ACR and duration of DM of three subgroups of patients according to their risk factor levels. Comparisons of individual clinical and laboratory variables between the three subgroups were assessed using oneway analysis of variance for the continuous data. Univariate logistic regression analysis was used to identify independent predictors of DAN during follow-up, in patients with type 2 DM who did not have DAN at baseline. A two-tailed P-value < 0.05 was considered to be statistically significant.
Results
In total, 271 Taiwanese patients with type 2 DM and 160 healthy volunteers were included in the study. Baseline characteristics and spectral analysis of R-R variability for both groups are given in Table 1 . There was no significant difference in age or in gender distribution between the patient and control groups. Spectral analysis of R-R variability showed significant between-group alterations in the autonomic nervous system. There were significant reductions in very low frequency [VLF], LF, HF and HRV in patients with type 2 DM compared with controls (P < 0.01 for all comparisons; Table 1 ).
The patients with DM were divided into six series (by BMI, TC level, 2-h PPG concentration, HbA 1c levels, ACR and duration of DM) of three subgroups according to their risk factor levels (Tables 2 Diabetic autonomic neuropathy and diabetic risk factors -4). Among the patients with DM, HbA 1c , 2h PPG concentration, TC, duration of DM and ACR decreased significantly in the autonomic nervous system (VLF and/or LF) as the risk factor status progressed. Similarly, BMI, HbA 1c and ACR decreased significantly in the autonomic nervous system (HF) as the risk factor status progressed.
Age, BMI, HbA 1c , ACR, TC and 2-h PPG concentrations were independent predictors of DAN in patients with type 2 DM in those who were free of DAN at baseline, and logistic regression analysis showed that BMI, HbA 1c , ACR, TC and 2-h PPG concentration were all significantly associated with a higher risk for developing DAN (Table 5 ). 
TABLE 1: Baseline characteristics and spectral analysis of R-R variability domain parameters between Taiwanese patients with diabetes mellitus (DM) and healthy control subjects
Discussion
There were three major findings from the present study. First, there was a statistically significant difference in autonomic nervous system function between patients with type 2 DM and controls. Secondly, patients with DM who had relatively greater values in DM duration, HbA 1c and TC levels, 2-h PPG concentrations and ACR showed significantly decreased values in the LF or VLF components of the spectral analysis; i.e. a decrease in sympathetic control. Thirdly, patients with DM who had higher values of the risk factors BMI, HbA 1c and ACR had significantly decreased values in the HF component of the spectral analysis; i.e. a decrease in parasympathetic control, compared with patients with lower values.
In DAN, parasympathetic impairment occurs earlier than sympathetic involvement. 24 The results from the present study indicated that spectral analysis of R-R variability provided a quantitative measure of autonomic nerve activity in patients with diabetes and in healthy subjects. Yamasaki et al. 25 showed that sympathetic stimuli (such as tilting or augmented LF) and parasympathetic stimuli (such as controlled breathing) increased HF. Pomeranz et al. 26 and Pagani et al. 24 indicated that β-adrenergic receptor blockage blunted the increase in LF during active or positive standing (i.e. after 30 min at rest in the supine position, the patient is asked to stand and to remain standing for 15 min). In addition, they showed that HF disappeared after atropine administration. These data indicate that LF and HF could represent clinically useful indices of sympathetic and vagal activities, respectively. Further follow-up spectral analysis of R-R variability might clarify the natural history of early stage DAN, which could not be evaluated by other methods. There was a correlation between the risk factors HbA 1c , ACR and BMI and DAN parasympathetic impairment in the present study.
The precise diagnosis of the stage of DM nephropathy has obvious clinical and prognostic implications. The aim of the present study was to evaluate the correlation between the stage of DM nephropathy and diabetic neuropathy. The data demonstrated that DM nephropathy and autonomic neuropathy co-exist in patients with type 2 DM. In adult patients with type 1 DM, a relationship has been demonstrated between 
